Testosterone bolsters insulin sensitivity in men with diabetes

05/6/2013 | MedPage Today (free registration)

Testosterone replacement therapy fared better than placebo in boosting insulin sensitivity in men with type 2 diabetes and hypogonadotropic hypogonadism, a study presented at the American Association of Clinical Endocrinologists annual meeting revealed. Researchers also found those who underwent testosterone treatment showed better lean mass, total fat, C-reactive protein and free fatty acids compared with those in the placebo group.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA